Why Clarity Pharmaceuticals, Life360, Ramsay Health Care, and Spartan Resources Shares Are Rising Today
The S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Tuesday and is trading slightly lower. In afternoon trade, the benchmark index is down 0.1% to 7,754.1 points.
Why These 4 ASX 200 Shares Were Just Rerated by Top Brokers
Four well-known S&P/ASX 200 Index (ASX: XJO) shares were just rerated by leading brokers.
Ramsay Health Care (ASX:RHC) Investors Are Sitting on a Loss of 25% If They Invested Five Years Ago
Ramsay Health Care Price Target Cut 8% to A$50.50/Share by Jefferies
Ramsay Health Care Price Target Cut 8% to A$50.50/Share by Jefferies
Ramsay Among 'Second Half Club' With 2H Earnings Skew -- Market Talk
2235 GMT - Which ASX-listed stock could follow Sonic Healthcare in downgrading earnings guidance? Macquarie points out that Downer EDI, Lovisa, Ramsay Health Care and Reliance Worldwide have a high ea
Ramsay's U.K. Performance Looking Healthier -- Market Talk
0107 GMT - Ramsay Health Care's performance in the U.K. is perking up, says Jarden. It notes the NHS is relying more on the private sector to clear a backlog of acute surgeries. Analyst Steve Wheen sa
Ramsay Health Care Price Target Raised 1.4% to A$64.30/Share by Jarden
Ramsay Health Care Price Target Raised 1.4% to A$64.30/Share by Jarden
Jarden Adjusts Ramsay Health Care Price Target to AU$64.30 From AU$64.43, Keeps at Neutral
Ramsay Health Care (ASX:RHC) has an average rating of hold and price targets ranging from AU$50.00 to AU$68.00, according to analysts polled by CapitalIQ. Price (AUD): $50.79, Change: $+0.68, Percent
Ramsay Health Care (ASX:RHC) Will Be Hoping To Turn Its Returns On Capital Around
Ramsay Health Care Limited's (ASX:RHC) Recent 3.7% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures
These ASX 200 Shares Could Rise 20% to 40%
If you're looking for big returns for your portfolio, then now could be a good time to check out the ASX 200 shares listed below.
JPMorgan Downgrades Ramsay Health Care to Underweight From Neutral; Price Target Is AU$50
Ramsay Health Care (ASX:RHC) has an average rating of hold and price targets ranging from AU$50.00 to AU$68.00, according to analysts polled by CapitalIQ. Price (AUD): $56.51, Change: $+0.24, Percent
Ramsay's Property Portfolio Could Be Worth A$7.1 Billion -- Market Talk
2156 GMT - Macquarie thinks the value of Ramsay Health Care's property portfolio is significantly larger than its operating business. In a note, Macquarie estimates the private-hospital portfolio is w
Ramsay's Share Price Could Rise on Sale of French JV Stake -- Market Talk
2150 GMT - Ramsay Health Care shares would likely rise if it sells its stake in the Ramsay Santé private-hospital business in France, Macquarie says. The bank assumes an Ebitda multiple of 10.0x in a
Ramsay Health Care Ltd's Dividend Analysis
Ramsay Health Care May Have to Wait Until 2033 For Margins to Recover -- Market Talk
1745 ET - It will be years before Ramsay Health Care's profit margins go back to where they were before the Covid-19 pandemic, Barrenjoey analyst Saul Hadassin says in a note. "In Australia, we foreca
Ramsay Health Care Target Price Raised 3.2% to A$51.61/Share by Wilsons>RHC.AU
Ramsay Health Care Target Price Raised 3.2% to A$51.61/Share by Wilsons>RHC.AU
ASX Earnings Wrap: Atlas Arteria's Profits Rise, Ramsay Healthcare Cuts Dividend
Ramsay Health Care Ltd (ASX:RHC), a private hospital operator, has announced a 20% cut in its interim dividend in response to escalating inflation in the medical sector. The dividend has been reduced to 40¢ per share, a significant drop from 50¢ per share a year ago.
Ramsay Just Scotched Potential Consensus Earnings Cuts -- Market Talk
0001 GMT - Private hospital operator Ramsay Health Care's 1H result was better than Wilson expected. Group revenue of A$8.2 billion was 7% ahead of the bank's estimate, while Ebitda of A$1.04 billion
Ramsay Health Care Reviews Portfolio After 1H Net Profit Fall
Ramsay Health Care said it is actively reviewing ways to unlock value from its portfolio of global hospitals after half-year net profit from continuing operations fell by 40%.
No Data